India's Cipla jumps on quarterly profit beat

Cipla

25/07/2025 09:02

** Shares of drugmaker Cipla CIPL.NS climb 2.7% to 1,527.6 rupees; top gainer on benchmark Nifty 50 index .NSEI, which is down 0.8%

** India's No.3 drugmaker by sales reported first-quarter profit that beat estimates, with consol net profit rising 10% on-year to 12.98 billion rupees (~$150 million)

** Stock was trading flat ahead of results

** CIPL rated "buy" on avg, median PT at 1,675 rupees - data compiled by LSEG

** Session's gains reverse YTD losses, stock now up 0.1% so far in 2025

($1 = 86.5750 Indian rupees)

 (Reporting by Manvi Pant in Bengaluru)

 ((Manvi.Pant@thomsonreuters.com; +918447554364;))